Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

about

Design, Synthesis and Characterization of N-oxide-containing Heterocycles with In vivo Sterilizing Antitubercular Activity.

P2860

Q41992338-B5A3C10C-213A-4B1E-B82A-52561DCD8676

P2860

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

Item

http://www.wikidata.org/entity/Q39354581

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@en

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@nl

type

Item

label

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@en

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@nl

prefLabel

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@en

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@nl

P1476

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

@en

P2093

Chung Man Chin

http://www.w3.org/2001/XMLSchema#string

Jean Leandro Dos Santos

http://www.w3.org/2001/XMLSchema#string

P2860

The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning

Nitroimidazoles for the treatment of TB: past, present and future

Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis

Steady-state and pre-steady-state kinetic analysis of Mycobacterium tuberculosis pantothenate synthetase

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds.

Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.

P31

scholarly article

P356

10.3390/PH10020051

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guilherme Felipe Dos Santos Fernandes

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28587160

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

5490408

http://www.w3.org/2001/XMLSchema#string

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

about

P2860

P2860

Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P921

P932